(Decision tree classifying cases based on whether their duration is 14 days or less, with the technique used (VMAT or other) as a splitting criterion. by Mohammad Bakhtiari (11838264)

The department’s daily management system, a part of a broader quality management system, ensures a seamless flow of information between all components based on the guidelines [ by Mohammad Bakhtiari (11838264)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Base-case analysis. by Yiping An (20609789)

“…At a CET of 0.51 times GDP per capita (US$6,394.536), the base-case analysis showed that the incremental costs of AOM relative to PP1M after 10 years of treatment were US$1,926.373 with an incremental gain of 0.306 QALYs. …”

Map of Pakistan with marked Punjab province. by Sumaira Sumaira (21453523)

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

PLB is a target gene of miRNA 221. by Hongyu Li (1332669)

<i>In silico</i> knockdown predictions on the basis of crosstalk models. by Elsje J. Burgers (20903422)

Subjects:

Crosstalk models to describe DEM-induced DDR activity. by Elsje J. Burgers (20903422)

Subjects:

Crosstalk models to describe etoposide-induced OSR activity. by Elsje J. Burgers (20903422)

Subjects:

DDR model describes data from HepG2 cells exposed to etoposide. by Elsje J. Burgers (20903422)

Subjects:

OSR model describes data from HepG2 cells exposed to DEM when NRF2 stimulates KEAP1 production. by Elsje J. Burgers (20903422)

Subjects:

Base-case cost-effectiveness results. by Yi Lin (49406)

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

A. Cost-effectiveness plane for the base case with QALY as outcome measure. by Ruben M.W.A. Drost (21647598)

A. Cost-effectiveness plane for the base case with GARS-4 as outcome measure. by Ruben M.W.A. Drost (21647598)

Results of base case. by Dunming Xiao (20531096)

“…Ischemic heart disease, heart failure, and myocardial infarction (stroke) decreased by 0.8%, 1.1%, and 4.7%, respectively. In the base-case analysis, IDegLira compared to the combined regimen shows an incremental cost of -34,254 CNY and an incremental QALYs of 0.436. …”

Base-case results. by Mingxi Xie (19812594)

“…The model time-frame was one-year. Base-case analysis and sensitivity analysis were performed. …”

Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)